Allogene (ALLO) 2025 Earnings: Milestones and Outlook
As allogene (allo) 2025 earnings loom, investors weigh pipeline progress, collaboration milestones, and cash runway. ...
This piece offers concrete examples of price, market-cap, and equal weighting schemes, illustrating how each affects index composition and risk.
4,753 articlesAs allogene (allo) 2025 earnings loom, investors weigh pipeline progress, collaboration milestones, and cash runway. ...
A recent SEC filing shows Brightlight Capital trimmed its Hilton stake by 79,500 shares, reducing the position's valu...
The S&P 500 surged to a new high driven by a small group of mega-cap tech giants, even as hundreds of other component...
Two leading travel platforms, Booking Holdings and Airbnb, each chart different revenue paths. This article breaks do...
When the investor who amassed the most Bitcoin recently sold a tiny slice, markets reacted more than the amount warra...
Bitcoin steadied near $64,000 after the Fed kept rates unchanged but shifted the outlook toward possible hikes. Marke...
As tech swings create headlines, a $34 ETF offering broad exposure with built in volatility controls rises as a safer...
Fannie Mae and Freddie Mac publish historical FICO 10T data and broaden VantageScore 4.0 files, offering lenders a ne...
A fresh framework shows a simple trio of ETFs may match the glide-path goals of target-date funds for those planning ...
Investors often chase big biotech gains, but Viking Therapeutics stock really hinges on milestones and cash runway. T...
A midrange, budget-friendly Apple device could broaden the company’s market and boost services revenue. This guide an...
Two popular small-cap ETFs, ISCB and SPSM, aim to capture the growth of U.S. small companies. This guide explains how...